• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在管理式医疗环境中提高高血压护理质量的机会。

Opportunities for improving the quality of hypertension care in a managed care setting.

作者信息

Godley P, Pham H, Rohack J, Woodward B, Yokoyama K, Maue S K

机构信息

Department of Pharmacy, Scott and White Hospital, 2401 South 31st Street, Temple, TX 76508, USA.

出版信息

Am J Health Syst Pharm. 2001 Sep 15;58(18):1728-33. doi: 10.1093/ajhp/58.18.1728.

DOI:10.1093/ajhp/58.18.1728
PMID:11571815
Abstract

Hypertension management practices and patient health outcomes in a managed care setting were evaluated. Health-system pharmacists analyzed plan medical and pharmacy claims data for September 1, 1998, to August 31, 1999, to identify hypertensive enrollees (n = 23,316). Reviews of pharmacy claims and medical charts of a sample of hypertensive patients (n = 374) determined blood pressure control status, prevalence of cardiovascular risk factors, and comorbidities. The majority of patients treated for hypertension (66%) did not achieve blood pressure control. Analysis revealed a high prevalence of cardiovascular risk factors among hypertensive patients, with 92.2% of study patients having two or more risk factors. Reviews of 132,512 pharmacy claims revealed that one half of all prescribed therapies were for monotherapy, and 21% of hypertensive patients were prescribed combination therapy with two different agents. Data from a large managed care organization revealed that more than half of all hypertensive patients had inadequate blood pressure control. A quality improvement program for hypertension care that can improve patient health outcomes must educate patients and health care providers about the implications of the disease, identify patients with compelling comorbidities, evaluate pharmacologic regimens, and recommend therapeutic changes when necessary.

摘要

对管理式医疗环境中的高血压管理实践和患者健康结局进行了评估。卫生系统药剂师分析了1998年9月1日至1999年8月31日的计划医疗和药房理赔数据,以确定高血压参保者(n = 23,316)。对一部分高血压患者(n = 374)的药房理赔和病历进行审查,以确定血压控制状况、心血管危险因素的患病率和合并症。大多数接受高血压治疗的患者(66%)未实现血压控制。分析显示高血压患者中心血管危险因素的患病率很高,92.2%的研究患者有两种或更多危险因素。对132,512份药房理赔的审查显示,所有处方治疗中有一半是单一疗法,21%的高血压患者接受了两种不同药物的联合治疗。来自一个大型管理式医疗组织的数据显示,超过一半的高血压患者血压控制不佳。一个能够改善患者健康结局的高血压护理质量改进项目必须让患者和医疗服务提供者了解该疾病的影响,识别有严重合并症的患者,评估药物治疗方案,并在必要时建议治疗调整。

相似文献

1
Opportunities for improving the quality of hypertension care in a managed care setting.在管理式医疗环境中提高高血压护理质量的机会。
Am J Health Syst Pharm. 2001 Sep 15;58(18):1728-33. doi: 10.1093/ajhp/58.18.1728.
2
Improving hypertension care in a large group-model MCO.改善大型团体模式管理式医疗组织中的高血压护理。
Am J Health Syst Pharm. 2003 Mar 15;60(6):554-64. doi: 10.1093/ajhp/60.6.554.
3
Assessment of drug therapy management and the prevalence of heart failure in a managed care population with hypertension.对高血压管理式医疗人群中药物治疗管理及心力衰竭患病率的评估。
J Manag Care Pharm. 2004 Nov-Dec;10(6):513-20. doi: 10.18553/jmcp.2004.10.6.513.
4
Implementing the new HEDIS hypertension performance measure.实施新的医疗效果数据和信息集(HEDIS)高血压绩效指标。
Manag Care. 2000 Apr;9(4 Suppl):2-17; quiz 18-21.
5
Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care.医疗补助管理式医疗下患者抗高血压药物续方失败的风险因素
Clin Ther. 1996 Nov-Dec;18(6):1252-62. doi: 10.1016/s0149-2918(96)80080-4.
6
Management Practices in Indian Patients with Uncontrolled Hypertension.印度未控制高血压患者的管理实践
J Assoc Physicians India. 2016 Jul;64(7):14-21.
7
The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.家庭血压评估和联合降压治疗在实现目标血压控制方面的治疗重要性:茨城县高血压评估试验。
Hypertens Res. 2010 Dec;33(12):1264-71. doi: 10.1038/hr.2010.175. Epub 2010 Oct 7.
8
Impact of combination therapy on managed care. Based on a presentation by Lisa Latts, MD, MSPH.联合治疗对管理式医疗的影响。基于医学博士、公共卫生硕士丽莎·拉茨的一次演讲。
Am J Manag Care. 1999 Jun;5(7 Suppl):S456-60; discussion S460-2.
9
Evaluation of a hypertension medication therapy management program in patients with diabetes.糖尿病患者高血压药物治疗管理项目的评估
J Am Pharm Assoc (2003). 2009 Mar-Apr;49(2):164-70. doi: 10.1331/JAPhA.2009.08164.
10
Treatment of hypertension in a managed care setting.在管理式医疗环境中治疗高血压。
Am J Manag Care. 2001 May;7(5):520-4.

引用本文的文献

1
Pharmacist intervention in improving hypertension-related knowledge, treatment medication adherence and health-related quality of life: a non-clinical randomized controlled trial.药剂师干预对改善高血压相关知识、治疗药物依从性及健康相关生活质量的影响:一项非临床随机对照试验
Health Expect. 2015 Oct;18(5):1270-81. doi: 10.1111/hex.12101. Epub 2013 Jun 20.
2
Tianma Gouteng Yin Formula for treating primary hypertension.天麻钩藤饮治疗原发性高血压
Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD008166. doi: 10.1002/14651858.CD008166.pub2.
3
Does treatment adherence correlates with health related quality of life? Findings from a cross sectional study.
治疗依从性与健康相关生活质量相关吗?一项横断面研究的结果。
BMC Public Health. 2012 Apr 30;12:318. doi: 10.1186/1471-2458-12-318.
4
Pharmacist intervention program to enhance hypertension control: a randomised controlled trial.药师干预方案对高血压控制的影响:一项随机对照试验。
Int J Clin Pharm. 2011 Feb;33(1):132-40. doi: 10.1007/s11096-010-9474-x. Epub 2011 Jan 13.